Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.
about
Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human healthSterol Biosynthesis and Azole Tolerance Is Governed by the Opposing Actions of SrbA and the CCAAT Binding ComplexDiscovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossingInvestigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence.First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosisClonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates.The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.Phylogenetic analyses on the diversity of Aspergillus fumigatus sensu lato based on five orthologous loci.Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaAntifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, JapanRapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.Environmental isolates of azole-resistant Aspergillus fumigatus in GermanyIn Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatusResistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.Azole preexposure affects the Aspergillus fumigatus population in patients.Fitness Studies of Azole-Resistant Strains of Aspergillus fumigatus.cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.Challenges in microbiological diagnosis of invasive Aspergillus infections.Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.Managing fungal and viral infections in pediatric leukemia.Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?Assessment of selection and resistance risk for demethylation inhibitor fungicides in Aspergillus fumigatus in agriculture and medicine: a critical review.Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.Mechanisms of Antifungal Drug Resistance.Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.Isavuconazole: a new extended spectrum triazole for invasive mold diseases.Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.Azole-resistant Aspergillus fumigatus in sawmills of Eastern France.In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.Determination of antifungal susceptibility patterns among the environmental isolates of Aspergillus fumigatus in Iran.
P2860
Q26999421-9C2A7DAF-CD36-4AEF-87BC-8F501374795DQ27312432-308EECC0-8F3E-47C3-AEA0-6C0B859E5F9BQ28485433-E24E9A19-1279-4FFF-A371-71914AD10A44Q29994504-7FC12AAD-EF37-4128-98F9-CB65EFA45E73Q33843857-26F8A7FB-5E09-4869-9669-874FC620A6E6Q34057414-143DDBDD-CCF3-4A74-99F8-8FDD2DB3F2A4Q34290034-1BF2B7A7-6E28-45DE-9B21-79E21F02D281Q34534761-9BB36A16-779D-482E-83FE-FAE16B75B5CBQ34977071-82498BA7-F52A-4516-8F44-F4C6D60FEAA6Q35076940-17D62282-5C0A-444E-8DC7-E0A81D71FB5FQ35222097-BFCB94BD-C255-43FD-85E2-D1ACC2A4AEF5Q35585364-EDAF46CF-0CD5-4540-9FC6-C01AB1207CF4Q35666518-F84FDF3B-B855-4B7C-906B-B57F6A4D54FDQ35666591-20B06BB4-C3F7-4251-B20F-B22AB06D11A5Q35689428-A06E460C-8F28-4F35-965A-AAD521999CDBQ35746043-46B68F34-E132-483E-9A68-D5DB4E67B1FEQ35746075-FB1CAAA8-8BFC-4490-A696-1A57AE720C16Q35804253-2D7803C7-FEF8-4DFE-9268-0DD8398D092FQ36118607-B261732D-1A35-457B-A3FE-03ABD31DF5B4Q36172416-CCDFFB33-9522-4349-A62D-B6838C788AFDQ36172445-C0732C7D-7D5C-41F1-9C1D-1BD6E1EB034FQ36290741-2DBE15D2-C815-4E19-9AD6-7895A409A124Q37036556-FF774B7D-6205-4100-8C00-BE3601D7B805Q37603643-2A767CA8-65BB-4B68-9ACF-68B596BE5397Q37659157-271161E4-A3E2-4E3F-AB27-BD3995ED7547Q37783285-9578D3E4-91DA-4A01-BDEE-0C0CE72A1918Q37810281-8BE6C801-7257-40C5-ABDE-12E1DB8A804AQ37813420-8B6EF836-0055-4A12-A173-96B3299262EAQ37859397-25859B1B-537B-4E48-B939-B164FE414463Q38152396-828706C9-51CA-437A-BE99-DE04590B310FQ38206867-CF6FCFE0-2C88-4E8B-9594-3C48DFCEA082Q38222570-CCF6931B-3433-4C35-B9FD-8542A115238CQ38266675-43E12D83-E73B-4456-8C22-5DF0BD4520ACQ38283306-BEF26107-A3E1-402D-9748-DE47FA038E22Q38725931-D360901C-D357-4049-BE4C-FACB094BB66FQ39003715-C4EBD8AD-F830-4179-9BD2-5D7338A63D23Q40035285-C85E4D26-F59D-4EEE-8F46-250B2831E5C2Q40215709-79AABDEF-8546-49F7-BB00-E53A40413315Q40325403-5CA0CE81-92B4-4073-8D9D-7E23421A0DB4Q41108420-A50ABEF1-245F-49DC-BC64-E14E4BC938B5
P2860
Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of azole resistanc ...... ated with change in virulence.
@ast
Development of azole resistanc ...... ated with change in virulence.
@en
Development of azole resistanc ...... ated with change in virulence.
@nl
type
label
Development of azole resistanc ...... ated with change in virulence.
@ast
Development of azole resistanc ...... ated with change in virulence.
@en
Development of azole resistanc ...... ated with change in virulence.
@nl
prefLabel
Development of azole resistanc ...... ated with change in virulence.
@ast
Development of azole resistanc ...... ated with change in virulence.
@en
Development of azole resistanc ...... ated with change in virulence.
@nl
P2093
P2860
P50
P1433
P1476
Development of azole resistanc ...... iated with change in virulence
@en
P2093
Eleftheria Mavridou
Humara Khan
Niels Frimodt-Møller
P2860
P304
P356
10.1371/JOURNAL.PONE.0010080
P407
P577
2010-04-09T00:00:00Z